トスフロキサシン
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2012/10/24 12:00:49」(JST)
[Wiki en表示]
Tosufloxacin
|
Systematic (IUPAC) name |
7-(3-Aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid |
Clinical data |
AHFS/Drugs.com |
International Drug Names |
Pregnancy cat. |
? |
Legal status |
? |
Identifiers |
CAS number |
100490-36-6 Y |
ATC code |
None |
PubChem |
CID 5517 |
UNII |
GHJ553KQPS N |
KEGG |
D02317 Y |
ChEMBL |
CHEMBL273348 N |
Chemical data |
Formula |
C19H15F3N4O3 |
Mol. mass |
404.34 g/mol |
N (what is this?) (verify)
|
Tosufloxacin is a fluoroquinolone antibiotic. It has a controversial safety profile in relation to other fluoroquinolones. It is associated with severe thrombocytopenia and nephritis, and hepatotoxicity.[1] It is sold in Japan under the brand name Ozex.
See also
- Fluoroquinolone
- Fluoroquinolone toxicity
References
- ^ Rubinstein, E. (2001). "History of quinolones and their side effects.". Chemotherapy 47 Suppl 3: 3–8; discussion 44–8. doi:10.1159/000057838. PMID 11549783.
Antibacterials: nucleic acid inhibitors (J01E, J01M)
|
|
Antifolates
(inhibits
purine metabolism,
thereby inhibiting
DNA and RNA synthesis) |
DHFR inhibitor |
- 2,4-Diaminopyrimidine
- Trimethoprim#
- Brodimoprim
- Tetroxoprim
- Iclaprim†
|
|
Sulfonamides
(DHPS inhibitor) |
Short-
acting |
- Sulfaisodimidine
- Sulfamethizole
- Sulfadimidine
- Sulfapyridine
- Sulfafurazole
- Sulfanilamide
- Sulfathiazole
- Sulfathiourea
|
|
Intermediate-
acting |
- Sulfamethoxazole
- Sulfadiazine#
- Sulfamoxole
|
|
Long-
acting |
- Sulfadimethoxine
- Sulfadoxine
- Sulfalene
- Sulfametomidine
- Sulfametoxydiazine
- Sulfamethoxypyridazine
- Sulfaperin
- Sulfamerazine
- Sulfaphenazole
- Sulfamazone
|
|
|
Other/ungrouped |
- sulfanilamide
- Sulfacetamide
- Sulfametrole
|
|
Combinations |
- Trimethoprim/sulfamethoxazole#
|
|
|
Topoisomerase
inhibitors/
quinolones/
(inhibits
DNA replication) |
1st g. |
- Cinoxacin‡
- Flumequine
- Nalidixic acid
- Oxolinic acid
- Pipemidic acid
- Piromidic acid
- Rosoxacin
|
|
Fluoro-
quinolones |
2nd g. |
- Ciprofloxacin#
- Enoxacin‡
- Fleroxacin‡
- Lomefloxacin
- Nadifloxacin
- Ofloxacin
- Norfloxacin
- Pefloxacin
- Rufloxacin
|
|
3rd g. |
- Balofloxacin
- Grepafloxacin‡
- Levofloxacin
- Pazufloxacin
- Sparfloxacin‡
- Temafloxacin‡
- Tosufloxacin
|
|
4th g. |
- Besifloxacin
- Clinafloxacin†
- Garenoxacin
- Gemifloxacin
- Moxifloxacin
- Gatifloxacin‡
- Sitafloxacin
- Trovafloxacin‡/Alatrofloxacin‡
- Prulifloxacin
|
|
Vet. |
- Danofloxacin
- Difloxacin
- Enrofloxacin
- Ibafloxacin
- Marbofloxacin
- Orbifloxacin
- Pradofloxacin
- Sarafloxacin
|
|
Related (DG) |
- Aminocoumarins: Novobiocin
|
|
|
|
Anaerobic DNA
inhibitors |
Nitro- imidazole derivatives |
- Metronidazole#
- Tinidazole
- Ornidazole
|
|
Nitrofuran derivatives |
- Nitrofurantoin#
- Furazolidone‡
- Nifurtoinol
|
|
|
RNA synthesis |
Rifamycins/
RNA polymerase |
- Rifampicin#
- Rifabutin
- Rifapentine
- Rifaximin
|
|
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
|
|
gr+f/gr+a(t)/gr-p(c)/gr-o
|
|
|
|
|
English Journal
- Moxifloxacin is more effective than tosufloxacin in reducing chemotherapy-induced febrile neutropneia in patients with hematological malignancies.
- Shinohara A, Yoshiki Y, Masamoto Y, Hangaishi A, Nannya Y, Kurokawa M.SourceDepartment of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo , Tokyo , Japan.
- Leukemia & lymphoma.Leuk Lymphoma.2013 Jan 2. [Epub ahead of print]
- Recent studies have shown the prophylactic efficacy of fluoroquinolones against infections in patients with chemotherapy-induced neutropenia. However, little is known about the differences between fluoroquinolones, and there are some concerns about the emergence of resistant bacteria. In this retros
- PMID 22978686
- Rapid Effectiveness of Minocycline or Doxycycline Against Macrolide-Resistant Mycoplasma pneumoniae Infection in a 2011 Outbreak Among Japanese Children.
- Okada T, Morozumi M, Tajima T, Hasegawa M, Sakata H, Ohnari S, Chiba N, Iwata S, Ubukata K.SourceDepartment of Pediatrics, National Hospital Organization Tokyo Medical Center.
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.Clin Infect Dis.2012 Dec;55(12):1642-9. doi: 10.1093/cid/cis784. Epub 2012 Sep 12.
- Background. Mycoplasma pneumoniae is a major pathogen causing community-acquired pneumonia in children and young adults. Outbreaks typically occur at intervals of several years. In 2011, a widespread outbreak was associated with macrolide-resistant M. pneumoniae (MRMP) in Japanese children, often
- PMID 22972867
Japanese Journal
- ヒト培養細胞内侵入Haemophilus influenzaeに対するトスフロキサシンの影響 : インフルエンザ菌による小児急性中耳炎反復メカニズムの視覚化と治療の可能性
- 2013年に気道感染症小児から分離されたA群溶血性レンサ球菌の細菌学的検討―過去4回の調査成績と比較して―
- 小児マイコプラズマ感染症の治療期間に影響を与える要因の探索
Related Links
- Tosufloxacin [TFLX] トスフロキサシン, 合成抗菌剤(新キノロン系) 1. 商品名 先発品 オゼックス錠75/オゼックス錠150 【富山化学工業, 大正富山医薬品】 オゼックス細粒小児用15% 【富山化学工業, 大正富山医薬品】 トスキサシン錠 ...
- Tosufloxacinとは?goo Wikipedia (ウィキペディア) 。出典:Wikipedia(ウィキペディア)フリー百科事典。 Tosufloxacinとは - goo Wikipedia (ウィキペディア) gooトップ サイトマップ スタートページに設定 RSS ヘルプ メニューへスキップ ...
Related Pictures
★リンクテーブル★
[★]
- 英
- tosufloxacin
- 化
- トシル酸トスフロキサシン tosufloxacin tosilate、トスフロキサシントシル酸塩
- 商
- オゼックス、トスキサシン、トスフロ
[★]
- 関
- tosufloxacin